Evidence map›Paper›PMID 34942976›Full record

ReviewAntioxidants (Basel, Switzerland)2021

Reactive Oxygen Species as the Brainbox in Malaria Treatment.

Chinedu Ogbonnia Egwu, Jean-Michel Augereau, Karine Reybier, Françoise Benoit-Vical

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Revisiting Glutathione Transferases ofPharmaceuticals (Basel, Switzerland) · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Antimalarial Activity of Aqueous Extracts of Nasturtium (Molecules (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Chinedu Ogbonnia EgwuPharmaDev, UMR 152, Université de Toulouse, IRD, UPS, 31400 Toulouse, France.ORCID 0000-0003-3408-5471
Jean-Michel AugereauCNRS, LCC, Laboratoire de Chimie de Coordination, Université de Toulouse, 31077 Toulouse, France.ORCID 0000-0002-2847-1969
Karine ReybierPharmaDev, UMR 152, Université de Toulouse, IRD, UPS, 31400 Toulouse, France.
Françoise Benoit-VicalCNRS, LCC, Laboratoire de Chimie de Coordination, Université de Toulouse, 31077 Toulouse, France.ORCID 0000-0002-9468-4823
Centre National de la Recherche Scientifique · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several measures are in place to combat the worldwide spread of malaria, especially in regions of high endemicity. In part, most common antimalarials, such as quinolines and artemisinin and its derivatives, deploy an ROS-mediated approach to kill malaria parasites. Although some antimalarials may share similar targets and mechanisms of action, varying levels of reactive oxygen species (ROS) generation may account for their varying pharmacological activities. Regardless of the numerous approaches employed currently and in development to treat malaria, concerningly, there has been increasing development of resistance by

Indexed as

antimalarialsmalaria and oxidative stressPlasmodium falciparumROS

Identifiers

PMID34942976
PMCPMC8698694
OpenAlexW3215606788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.